Very early researchStudy completedNCT03423810
What this trial is testing
Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
Who this might be right for
Polycystic Kidney Diseases
University of Kansas Medical Center 14